Overexpression of tumour-ssociated carbohydrate antigen sialyl-Tn in advanced bladder tumours

Guía clínica del carcinoma urotelial de vejiga no músculo-invasivo de la Asociación Europea de Urología. Actualización de 2011

(2012) M. Babjuk et al.   Actas Urologicas Espanolas

Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model

(2012) Hidenori Ozaki et al.   CLINICAL & EXPERIMENTAL METASTASIS

Lectin bioconjugates trigger urothelial cytoinvasion – A glycotargeted approach for improved intravesical drug delivery

(2012) L. Neutsch et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Mechanisms of cancer-associated glycosylation changes

(2011) Fabio Dall'Olio   Frontiers in Bioscience-Landmark

Identification of new cancer biomarkers based on aberrant mucin glycoforms byin situproximity ligation

(2011) Rita Pinto et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer

(2011) D. Miles et al.   ONCOLOGIST

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

(2011) V. Lakshminarayanan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cancer vaccines and carbohydrate epitopes

(2011) Jamie Heimburg-Molinaro et al.   VACCINE

Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy

(2011) D. R. Yates et al.   WORLD JOURNAL OF UROLOGY

Tumor Antigen Epitopes Interpreted by the Immune System as Self or Abnormal-Self Differentially Affect Cancer Vaccine Responses

(2010) S. O. Ryan et al.   CANCER RESEARCH

Alterations in glycosylation as biomarkers for cancer detection

(2010) C. A Reis et al.   JOURNAL OF CLINICAL PATHOLOGY

ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines

(2009) Paula A Videira et al.   BMC CANCER

Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model

(2009) S Julien et al.   BRITISH JOURNAL OF CANCER

Emerging targeted therapies for bladder cancer: a disease waiting for a drug

(2009) Simon J. Dovedi et al.   CANCER AND METASTASIS REVIEWS

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas

(2009) Tim Conze et al.   GLYCOBIOLOGY

Bladder Cancer: Narrowing the Gap Between Evidence and Practice

(2009) Maha H.A. Hussain et al.   JOURNAL OF CLINICAL ONCOLOGY

Multi-Institutional Validation of the Predictive Value of Ki-67 Labeling Index in Patients With Urinary Bladder Cancer

(2009) V. Margulis et al.   JNCI-Journal of the National Cancer Institute

CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa

(2009) Carlos Palmeira et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines

(2009) Paula A. Videira et al.   UROLOGY

Economic aspects of bladder cancer: what are the benefits and costs?

(2009) K. D. Sievert et al.   WORLD JOURNAL OF UROLOGY

The present and future burden of urinary bladder cancer in the world

(2009) Martine Ploeg et al.   WORLD JOURNAL OF UROLOGY

Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc

(2008) T. Ju et al.   CANCER RESEARCH